Доказательно о травах. Научный подход к фитотерапии

19. Al-Karawi D, Al Mamoori DA, Tayyar Y. The role of curcumin administration in patients with major depressive disorder: mini meta-analysis of clinical trials. Phytother Res. 2016;30(2):175-183

20. Fanaei H, Khayat S, Kasaeian A, Javadimehr M. Effect of curcumin on serum brain-derived neurotrophic factor levels in women with premenstrual syndrome: a randomized, double-blind, placebo-controlled trial. Neuropeptides. 2015. Nov 11. pii: S0143-4179(15)00118-3. doi: 10.1016/j.npep.2015.11.003.

ГЛАВА 9

1. Zhang J, Wang A, Zhang X, Chen S, Wu S, Zhao X, Zhang Q. Association between tea consumption and cognitive impairment in middle-aged and older adults. BMC Geriatr. 2020 Nov 4;20(1):447. doi: 10.1186/s12877-020-01848-6. PMID: 33148194; PMCID: PMC7640442.

2. Sang S, Lambert JD, Ho CT, Yang CS. The chemistry and biotransformation of tea constituents. Pharmacol Res. 2011;64(2):87–99.

3. Mancini E, Beglinger C, Drewe J, Zanchi D, Lang UE, Borgwardt S. Green tea effects on cognition, mood and human brain function: A systematic review. Phytomedicine. 2017 Oct 15;34:26–37. doi: 10.1016/j.phymed.2017.07.008. Epub 2017 Jul 27. PMID: 28899506.

4. Abe, S.K., Inoue, M. Green tea and cancer and cardiometabolic diseases: a review of the current epidemiological evidence. Eur J Clin Nutr 75, 865–876 (2021). https://doi.org/10.1038/s41430-020-00710-7

5. Filippini T, Malavolti M, Borrelli F, Izzo AA, Fairweather-Tait SJ, Horneber M, Vinceti M. Green tea (Camellia sinensis) for the prevention of cancer. Cochrane Database Syst Rev. 2020 Mar 2;3(3):CD005004. doi: 10.1002/14651858.CD005004.pub3. PMID: 32118296; PMCID: PMC7059963.

6. Ma YH, Wu JH, Xu W, Shen XN, Wang HF, Hou XH, Cao XP, Bi YL, Dong Q, Feng L, Tan L, Yu JT. Associations of Green Tea Consumption and Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease Pathology in Cognitively Intact Older Adults: The CABLE Study. J Alzheimers Dis. 2020;77(1):411–421. doi: 10.3233/JAD-200410. PMID: 32804140.

7. Frontiers | Extra cup of tea intake associated with increased risk of Alzheimer’s disease: Genetic insights from Mendelian randomization (frontiersin.org)

8. Vyas T, Nagi R, Bhatia A, Bains SK. Therapeutic effects of green tea as an antioxidant on oral health– A review. J Family Med Prim Care. 2021 Nov;10(11):3998–4001. doi: 10.4103/jfmpc.jfmpc_943_21. Epub 2021 Nov 29. PMID: 35136758; PMCID: PMC8797077.

9. Xu, R., Bai, Y., Yang, K. et al. Effects of green tea consumption on glycemic control: a systematic review and meta-analysis of randomized controlled trials. Nutr Metab (Lond) 17, 56 (2020). https://doi.org/10.1186/s12986-020-00469-5

10. Kwak J, Shin D. Association between Green Tea Consumption and Abdominal Obesity Risk in Middle-Aged Korean Population: Findings from the Korean Genome and Epidemiology Study. Int J Environ Res Public Health. 2022 Feb 26;19(5):2735. doi: 10.3390/ijerph19052735. PMID: 35270427; PMCID: PMC8910422.

11. Zhang C, Qin YY, Wei X, Yu FF, Zhou YH, He J. Tea consumption and risk of cardiovascular outcomes and total mortality: a systematic review and meta-analysis of prospective observational studies. Eur J Epidemiol. 2015;30(2):103–113.

12. Tang J, Zheng JS, Fang L, Jin Y, Cai W, Li D. Tea consumption and mortality of all cancers, CVD and all causes: a meta-analysis of eighteen prospective cohort studies. Br J Nutr. 2015:1-11.

13. InterAct Consortium, van Woudenbergh GJ, Kuijsten A, et al. Tea consumption and incidence of type 2 diabetes in Europe: the EPIC–InterAct case-cohort study. PLoS One. 2012;7(5):e36910.

14. Zhong X, Zhang T, Liu Y, et al. Short-term weight-centric effects of tea or tea extract in patients with metabolic syndrome: a meta-analysis of randomized controlled trials. Nutr Diabetes. 2015;5:e160.

15. Noguchi-Shinohara M, Yuki S, Dohmoto C, et al. Consumption of green tea, but not black tea or coffee, is associated with reduced risk of cognitive decline. PLoS One. 2014;9(5):e96013.

16. Ide K, Yamada H, Takuma N, et al. Green tea consumption affects cognitive dysfunction in the elderly: a pilot study. Nutrients. 2014;6(10):4032-4042

ГЛАВА 10

1. De Franciscis, P., Colacurci, N., Riemma, G., Conte, A., Pittana, E., Guida, M., & Schiattarella, A. (2019). A Nutraceutical Approach to Menopausal Complaints. Medicina (Kau-nas, Lithuania), 55(9), 544. https://doi.org/10.3390/medicina 55090544

2. Nicoletti M. Nutraceuticals and botanicals: Overview and perspectives. Int. J. Food Sci. Nutr. 2012;63:2–6. doi: 10.3109/09637486.2011.628012.

3. Lethaby A, Marjoribanks J, Kronenberg F, Roberts H, Eden J, Brown J. Phytoestrogens for menopausal vasomotor symptoms. Cochrane Database Syst Rev. 2013(12):CD001395

4. Хашукоева АЗ, Маркова ЭА, Бурденко МВ, Носова ЛА, Соловьева АМ, Лукьянова ЕА. Менопаузальный переход. Можно ли отсрочить назначение менопаузальной гормональной терапии? Медицинский совет. 2023;17(15):126–133. https://doi.org/10.21518/ms2023-342.